MULTIPLE MYELOMA MONITORING PANEL
8500

This assay is helpful to assess changes and proportions of various proteins, particularly the M-protein, in a known case of Monoclonal gammopathy. It helps to track the progression of myeloma and the response to treatment. The level of β2-microglobulin reflects the tumour mass and is considered as a standard measure of the tumour burden. In addition, the FLC ratio is required for documenting stringent complete response according to the International Myeloma Working Group Uniform Response Criteria.

  • Test Type:
  • Pre-test Information:
  • Report Delivery:
    Sample Daily by 9 am; Report Next day
  • Components:
    0

Sample Report